Moderna Inc

MRNA: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
!>!LOCK|#Y@LOCK|t^Hhdj>

Moderna: Litigation Settlement Removes Royalty Risk; We Still Estimate Breakeven by 2029

Moderna has entered into a global settlement with Genevant Sciences and Arbutus Biopharma related to the latter firms' lipid nanoparticle technology used in Moderna's covid vaccines. Moderna shares rose 15% in intraday trading on March 4.

Sponsor Center